/

Other

/

Novavax

Novavax

Novavax

Verified Nov 2026

Other

·

United States flag

Gaithersburg, Maryland

·

Since 1987

Novavax is a biotechnology company founded in 1987 and headquartered in Gaithersburg, Maryland, with 500-1,000 employees and estimated revenue of $1-5 billion. The company develops and commercializes vaccines for serious infectious diseases, including its protein-based COVID-19 vaccine approved by the FDA in May 2025. Novavax operates facilities in Maryland, Sweden, and the Czech Republic and generated approximately $0.7 billion in revenue in fiscal 2024.

Novavax

Verified Nov 2026

AT A GLANCE

Founded

1987

Headquarters

United States flag

Gaithersburg, Maryland

Employees

500-1,000

Ownership

Novavax at a glance

Revenue

$1-5B

Est. band

Employees

500-1,000

Founded

1987

Headquarters

Gaithersburg, Maryland

Industries

Automotive

Electric Vehicles

Medical

Renewable Energy

Industrial Equipment

Overview

Novavax is a biotechnology company founded in 1987 and headquartered in Gaithersburg, Maryland, with 500-1,000 employees and estimated revenue of $1-5 billion. The company develops and commercializes vaccines for serious infectious diseases, including its protein-based COVID-19 vaccine approved by the FDA in May 2025. Novavax operates facilities in Maryland, Sweden, and the Czech Republic and generated approximately $0.7 billion in revenue in fiscal 2024.

At a glance

Attribute

Detail

Founded

1987

Headquarters

Gaithersburg, Maryland

Employees

500-1,000

Revenue

$1-5B (estimated)

What Novavax makes

The company utilizes proprietary Matrix-M adjuvant technology and nanoparticle protein-based platforms to enhance immune responses in vaccines targeting influenza, RSV, Ebola, and malaria.

Products and capabilities described on the company's own site include LED (source: novavax.com).

Latest developments

Facilities

Novavax is headquartered in Gaithersburg, Maryland. Public sources also reference these locations:

Company details

Novavax is publicly traded on NASDAQ under ticker NVAX and maintains operations across North America and Europe to support manufacturing and development activities. Novavax was founded in 1987, has an estimated 500-1,000 employees, and is headquartered in Gaithersburg, Maryland.

Frequently asked questions

What does Novavax do?

Novavax is a biotechnology company founded in 1987 and headquartered in Gaithersburg, Maryland, with 500-1,000 employees and estimated revenue of $1-5 billion. The company develops and commercializes vaccines for serious infectious diseases, including its protein-based COVID-19 vaccine approved by the FDA in May 2025. Novavax operates facilities in Maryland, Sweden, and the Czech Republic and generated approximately $0.7 billion in revenue in fiscal 2024.

Where is Novavax headquartered?

Novavax is headquartered in Gaithersburg, Maryland (21 Firstfield Rd, Gaithersburg, Maryland, 20878-1757).

When was Novavax founded?

Novavax was founded in 1987.

How big is Novavax?

Novavax has an estimated 500-1,000 employees, with revenue in the $1-5B range (estimated).

Related suppliers

Explore other suppliers in the LightSource directory:

Last verified Nov 2026. Is this your company? Request a correction.

Location & contact

Gaithersburg, Maryland (HQ)Headquarters · United States
Gaithersburg, Maryland (HQ)21 Firstfield Rd, Gaithersburg, Maryland, 20878-1757, United StatesHeadquarters

Evaluating suppliers like these?

This profile is part of a public-data sample of the full LightSource directory. Book a demo to see the full LightSource marketplace and supplier discovery platform — 1M+ credible suppliers, with AI-run sourcing events.